| pubmed-article:7884416 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7884416 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7884416 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
| pubmed-article:7884416 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
| pubmed-article:7884416 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:7884416 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:7884416 | pubmed:dateCreated | 1995-4-7 | lld:pubmed |
| pubmed-article:7884416 | pubmed:abstractText | Despite improvement in chemotherapy and supportive care over the past two decades, overall survival for patients with acute myelogenous leukemia (AML) remains poor; only 25% to 30% of individuals with this disorder will be cured. In 1987, we initiated a prospective multiinstitution study designed to improve long-term survival in adults with AML. | lld:pubmed |
| pubmed-article:7884416 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7884416 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7884416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7884416 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7884416 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:7884416 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:7884416 | pubmed:author | pubmed-author:MillerK BKB | lld:pubmed |
| pubmed-article:7884416 | pubmed:author | pubmed-author:WheelerCC | lld:pubmed |
| pubmed-article:7884416 | pubmed:author | pubmed-author:RyanH FHF | lld:pubmed |
| pubmed-article:7884416 | pubmed:author | pubmed-author:SchenkeinD... | lld:pubmed |
| pubmed-article:7884416 | pubmed:author | pubmed-author:AntinJ HJH | lld:pubmed |
| pubmed-article:7884416 | pubmed:author | pubmed-author:MitusA JAJ | lld:pubmed |
| pubmed-article:7884416 | pubmed:author | pubmed-author:ParsonsS KSK | lld:pubmed |
| pubmed-article:7884416 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7884416 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:7884416 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7884416 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7884416 | pubmed:pagination | 560-9 | lld:pubmed |
| pubmed-article:7884416 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:meshHeading | pubmed-meshheading:7884416-... | lld:pubmed |
| pubmed-article:7884416 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7884416 | pubmed:articleTitle | Improved survival for patients with acute myelogenous leukemia. | lld:pubmed |
| pubmed-article:7884416 | pubmed:affiliation | Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115. | lld:pubmed |
| pubmed-article:7884416 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7884416 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7884416 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7884416 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:7884416 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7884416 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7884416 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7884416 | lld:pubmed |
